Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Non-Current Assets (2023 - 2025)

WORK Medical Technology filings provide 3 years of Non-Current Assets readings, the most recent being $12.7 million for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 17.65% to $12.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $12.7 million, a 17.65% decrease, with the full-year FY2025 number at $12.7 million, down 17.65% from a year prior.
  • Non-Current Assets hit $12.7 million in Q3 2025 for WORK Medical Technology, down from $13.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $15.4 million in Q3 2024 to a low of $7.8 million in Q3 2023.
  • Median Non-Current Assets over the past 3 years was $12.9 million (2025), compared with a mean of $12.3 million.
  • Biggest five-year swings in Non-Current Assets: surged 97.58% in 2024 and later decreased 17.65% in 2025.
  • WORK Medical Technology's Non-Current Assets stood at $7.8 million in 2023, then surged by 97.58% to $15.4 million in 2024, then decreased by 17.65% to $12.7 million in 2025.
  • The last three reported values for Non-Current Assets were $12.7 million (Q3 2025), $13.1 million (Q1 2025), and $15.4 million (Q3 2024) per Business Quant data.